Redhill Biopharma
RDHL
7 hedge funds and large institutions have $15.9M invested in Redhill Biopharma in 2014 Q2 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 1 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
17% more funds holding
Funds holding: 6 → 7 (+1)
2% more capital invested
Capital invested by funds: $15.5M → $15.9M (+$365K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MMG
Monetary Management Group
St Louis,
Missouri
|
+$63.5K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$15.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$2.43M |
| 2 |
O
OrbiMed
New York
|
-$413K |
| 3 |
U
UBS
Zurich,
Switzerland
|
-$4K |
| 4 |
Citigroup
New York
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
O
1
OrbiMed
New York
| $10.6M | -$413K | -26 | -4% |
|
|
BC
2
Broadfin Capital
New York
| $4.6M | – | – | – |
|
3
Goldman Sachs
New York
| $507K | – | – | – |
|
|
MMG
4
Monetary Management Group
St Louis,
Missouri
| $77K | +$63.5K | +4 | New |
|
5
Wells Fargo
San Francisco,
California
| $52K | – | – | – |
|
|
6
Bank of America
Charlotte,
North Carolina
| $17K | +$15.9K | +1 | New |
|
|
TRCT
7
Tower Research Capital (TRC)
New York
| $16K | – | – | – |
|
|
SFM
8
Sphera Funds Management
Tel Aviv,
Israel
| – | -$2.43M | -1,715 | Closed |
|
|
9
Citigroup
New York
| – | -$1K | – | – |
|
|
U
10
UBS
Zurich,
Switzerland
| – | -$4K | – | – |
|
RDHL Hedge Fund Activity: Q2 2014 in Review
7 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Redhill Biopharma (RDHL) for Q2 2014, worth a combined $15.9M — up 2.4% from $15.5M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new RDHL positions and 1 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.
The largest buyer was Monetary Management Group, opening a new position worth an estimated $63.5K. The largest seller was Sphera Funds Management, exiting entirely with an estimated $2.43M sold.
- 7 institutional investors held Redhill Biopharma (RDHL) as of Q2 2014, up from 6 in Q1 2014.
- Funds reported $15.9M of Redhill Biopharma stock for Q2 2014, up 2.4% quarter-over-quarter.
- 2 funds opened new Redhill Biopharma positions in Q2 2014 and 1 closed out, a net change of +1 holder.
- The largest Redhill Biopharma buyer in Q2 2014 was Monetary Management Group, an estimated $63.5K added.
- The largest Redhill Biopharma seller in Q2 2014 was Sphera Funds Management, an estimated $2.43M sold.
Based on aggregated 13F filings for Q2 2014.